AtoGen Co., Ltd.
PrivateLast Round
Strategic
Sep 15, 2022
Total Funding Raised
$14.06M
Company Overview
AtoGen Co., Ltd. is a biotechnology company that develops microbiome-based therapeutics and functional health ingredients using a proprietary screening platform and genomic analysis technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AtoGen Co., Ltd. Comparables
Compare AtoGen Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enterobiome Inc. | 80% | |
| KoBioLabs Inc | 79% | |
| GI Longevity | 79% | |
AtoGen Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Sep 15, 2022 | ||||
| VC Round | Jan 3, 2022 | ||||
| Series A | Jan 1, 2020 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2020
$7M round completed.
AtoGen Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AtoGen Co., Ltd.'s valuation, stock price, and market status.